Předmět: |
|
Zdroj: |
AIDS Weekly; 7/10/2023, p112-112, 1p |
Abstrakt: |
For more information on this research see: HIV remission trial investigators' attitudes towards risk and risk mitigation in trials that include treatment interruption. Keywords: Drugs and Therapies; HIV/AIDS; Health and Medicine; Immune System Diseases and Conditions; Primate Lentiviruses; RNA Viruses; Retroviridae; Risk and Prevention; Vertebrate Viruses; Viral Sexually Transmitted Diseases and Conditions EN Drugs and Therapies HIV/AIDS Health and Medicine Immune System Diseases and Conditions Primate Lentiviruses RNA Viruses Retroviridae Risk and Prevention Vertebrate Viruses Viral Sexually Transmitted Diseases and Conditions 112 112 1 07/10/23 20230710 NES 230710 2023 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Researchers detail new data in HIV/AIDS. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|